South Bend man benefits from cancer breakthrough – South Bend Tribune
South Bend Tribune |
South Bend man benefits from cancer breakthrough
South Bend Tribune If that FDA approval comes — and UCM is preparing for it to come very soon — UCM will have one of the only facilities in the Midwest certified to administer chimeric antigen receptor T-cell infusion, or CAR T-cell, a newer form of immunotherapy. |
